![Scrunchies Market 2022 to Showing Impressive Growth by | [No. of pages: 124] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research](https://www.99newser.com/wp-content/uploads/2022/05/934835f9b53bfc35497459b8b018252e-360x180.png)
Mumbai, in the meantime, on Friday reported 93 Covid-19 cases, taking the tally to 10,59,728, while the death toll remained unchanged at 19,562, a civic official said. Tamil Nadu recorded 54 new Covid-19 infections, pushing the total caseload in the state to 34,53,883.
In other news, at least 63 per cent parents say schools should make online classes available if district COVID-19 positivity rate crosses 5 per cent so that learning is not disrupted for impacted students, according to a new survey.
“Twenty-seven per cent of surveyed parents said once the Covid test positivity rate (TPR) in a district crosses 2 per cent, online classes should be started. While 63 per cent parents said if district TPR crosses 5 per cent, schools should make online classes also available so that learning is not disrupted for impacted students,” it said.
The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said on Friday. India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group, subject to certain conditions, on March 9.
“The COVID-19 working group of the NTAGI (National Technical Advisory Group on Immunisation) had earlier reviewed data related to Covovax and okayed it. The NTAGI’s Standing Technical Sub-Committee which met on Friday has recommended that the vaccine can be used for 12-17 years age group,” an official source said.
READ | NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group
